Forward Pharma A/S (Forward Pharma A/S) EPS without NRI : $-141.65 (TTM As of Jun. 2022)

Forward Pharma A/S EPS without NRI Chart

Forward Pharma A/S Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
EPS without NRI		Get a 7-Day Free Trial					9,201.86	-471.99	-191.93	-156.25	-168.78

Forward Pharma A/S Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
EPS without NRI	Get a 7-Day Free Trial															-69.95	-86.83	-76.73	-91.98	-49.67

Competitive Comparison of Forward Pharma A/S's EPS without NRI

For the Biotechnology subindustry, Forward Pharma A/S's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Forward Pharma A/S's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Forward Pharma A/S's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Forward Pharma A/S's PE Ratio without NRI falls into.

Forward Pharma A/S EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-141.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forward Pharma A/S  (OTCPK:FWPAY) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Forward Pharma A/S EPS without NRI Related Terms

Thank you for viewing the detailed overview of Forward Pharma A/S's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.

Forward Pharma A/S (Forward Pharma A/S) Business Description